A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight ... more evolved or potent medications come to market. At least 27 new GLP-1 drugs are currently ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace ... according to a study in The New England Journal of Medicine. Congenital generalized ...

Andrew Tenpas, PharmD, RPh, clinical assistant professor at the Texas A&M University Irma Lerma Rangel College of Pharmacy, explains the medications, their benefits and a few drawbacks.

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

The global diabetes drugs market size was valued at USD 79.25 ... in research and development activities and launching new products to maintain their competitive edge. For example, in July 2019 ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...